Literature DB >> 16511183

Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotate.

Daniel Ken Inaoka1, Eizo Takashima, Arihiro Osanai, Hironari Shimizu, Takeshi Nara, Takashi Aoki, Shigeharu Harada, Kiyoshi Kita.   

Abstract

Dihydroorotate dehydrogenase (DHOD) catalyzes the oxidation of dihydroorotate to orotate, the fourth step and the only redox reaction in the de novo biosynthesis of pyrimidine. DHOD from Trypanosoma cruzi (TcDHOD) has been expressed as a recombinant protein in Escherichia coli and purified to homogeneity. Crystals of the TcDHOD-orotate complex were grown at 277 K by the sitting-drop vapour-diffusion technique using polyethylene glycol 3350 as a precipitant. The crystals diffract to better than 1.8 A resolution using synchrotron radiation (lambda = 0.900 A). X-ray diffraction data were collected at 100 K and processed to 1.9 A resolution with 98.2% completeness and an overall Rmerge of 7.8%. The TcDHOD crystals belong to the orthorhombic space group P2(1)2(1)2(1), with unit-cell parameters a = 67.87, b = 71.89, c = 123.27 A. The presence of two molecules in the asymmetric unit (2 x 34 kDa) gives a crystal volume per protein weight (VM) of 2.2 A3 Da(-1) and a solvent content of 44%.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511183      PMCID: PMC1991314          DOI: 10.1107/S174430910502659X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  12 in total

1.  Post-translational modification of the N-terminal His tag interferes with the crystallization of the wild-type and mutant SH3 domains from chicken src tyrosine kinase.

Authors:  K M Kim; E C Yi; D Baker; K Y Zhang
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-04-24

2.  Evolutionary implications of the mosaic pyrimidine-biosynthetic pathway in eukaryotes.

Authors:  T Nara; T Hshimoto; T Aoki
Journal:  Gene       Date:  2000-10-31       Impact factor: 3.688

3.  E. coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases.

Authors:  Sofie Nørager; Kaj Frank Jensen; Olof Björnberg; Sine Larsen
Journal:  Structure       Date:  2002-09       Impact factor: 5.006

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

6.  Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents.

Authors:  S Liu; E A Neidhardt; T H Grossman; T Ocain; J Clardy
Journal:  Structure       Date:  2000-01-15       Impact factor: 5.006

7.  Characterization of the dihydroorotate dehydrogenase as a soluble fumarate reductase in Trypanosoma cruzi.

Authors:  Eizo Takashima; Daniel Ken Inaoka; Arihiro Osanai; Takeshi Nara; Masao Odaka; Takashi Aoki; Kozi Inaka; Shigeharu Harada; Kiyoshi Kita
Journal:  Mol Biochem Parasitol       Date:  2002-07       Impact factor: 1.759

8.  Novel organization and sequences of five genes encoding all six enzymes for de novo pyrimidine biosynthesis in Trypanosoma cruzi.

Authors:  G Gao; T Nara; J Nakajima-Shimada; T Aoki
Journal:  J Mol Biol       Date:  1999-01-08       Impact factor: 5.469

9.  The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function.

Authors:  P Rowland; O Björnberg; F S Nielsen; K F Jensen; S Larsen
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

10.  Spontaneous alpha-N-6-phosphogluconoylation of a "His tag" in Escherichia coli: the cause of extra mass of 258 or 178 Da in fusion proteins.

Authors:  K F Geoghegan; H B Dixon; P J Rosner; L R Hoth; A J Lanzetti; K A Borzilleri; E S Marr; L H Pezzullo; L B Martin; P K LeMotte; A S McColl; A V Kamath; J G Stroh
Journal:  Anal Biochem       Date:  1999-02-01       Impact factor: 3.365

View more
  3 in total

1.  Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies.

Authors:  Tracy L Arakaki; Frederick S Buckner; J Robert Gillespie; Nicholas A Malmquist; Margaret A Phillips; Oleksandr Kalyuzhniy; Joseph R Luft; George T Detitta; Christophe L M J Verlinde; Wesley C Van Voorhis; Wim G J Hol; Ethan A Merritt
Journal:  Mol Microbiol       Date:  2008-02-26       Impact factor: 3.501

2.  The Open Form Inducer Approach for Structure-Based Drug Design.

Authors:  Daniel Ken Inaoka; Maiko Iida; Toshiyuki Tabuchi; Teruki Honma; Nayoung Lee; Satoshi Hashimoto; Shigeru Matsuoka; Takefumi Kuranaga; Kazuhito Sato; Tomoo Shiba; Kimitoshi Sakamoto; Emmanuel Oluwadare Balogun; Shigeo Suzuki; Takeshi Nara; Josmar Rodrigues da Rocha; Carlos Alberto Montanari; Akiko Tanaka; Masayuki Inoue; Kiyoshi Kita; Shigeharu Harada
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

Review 3.  Fresh insights into the pyrimidine metabolism in the trypanosomatids.

Authors:  Kartikeya Tiwari; Vikash Kumar Dubey
Journal:  Parasit Vectors       Date:  2018-02-08       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.